An Overview of Lipid-Lowering Drugs
- 1 January 1988
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 36 (Supplement) , 63-71
- https://doi.org/10.2165/00003495-198800363-00015
Abstract
The long term use of lipid-lowering drugs in the treatment of patients with hyperlipoproteinaemia is aimed at reducing plasma concentrations of known atherogenic lipoproteins with a favourable effect...Keywords
This publication has 33 references indexed in Scilit:
- New horizons in combination drug therapy for hypercholesterolemia.1989
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988
- 3-Hydroxy-3-Methylglutaryl—Coenzyme A Reductase Inhibitors in the Treatment of HypercholesterolemiaJAMA, 1987
- Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial HypercholesterolemiaAnnals of Internal Medicine, 1987
- Lipid-Lowering DrugsDrugs, 1987
- Therapeutic Response to Lovastatin (Mevinolin) in Nonfamilial HypercholesterolemiaJAMA, 1986
- Comparative evaluation of the effects of ciprofibrate and fenofibrate on lipids, lipoproteins and apoproteins A and BAtherosclerosis, 1985
- Neomycin and plasma lipoproteins in type II hyperlipoproteinemiaClinical Pharmacology & Therapeutics, 1984
- Influence of nicotinic acid on metabolism of cholesterol and triglycerides in manJournal of Lipid Research, 1981
- TSH response to TRH in euthyroid, hypercholesterolemic patients treated with graded doses of dextrothyroxineMetabolism, 1981